Merck

Explore the latest insights on Merck and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Merck’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.Explore the latest insights on Merck and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Merck's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

European Commission Revokes Hansoh's Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute
CompanyDrug

European Commission Revokes Hansoh’s Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute

Hansoh Pharmaceutical Group Company Limited (HKG: 3692) announced that the European Commission (EC) has revoked the marketing authorization for Aumolertinib, just seven months after its EU approval in February 2026.…

Merck's Subcutaneous Pembrolizumab Approved by China's NMPA Across 19 Solid Tumor Indications – First and Only Subcutaneous PD‑1 Inhibitor in China

Merck’s Subcutaneous Pembrolizumab Approved by China’s NMPA Across 19 Solid Tumor Indications – First and Only Subcutaneous PD‑1 Inhibitor in China

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Company

Merck KGaA Launches Uptune Program in Asia, Offers Startups Up to €100,000

CompanyDrug

Eucure Biopharma Doses First Patient in YH003 + Keytruda Trial for Mucosal Melanoma

Company

Organon’s China Head Shi Wang Departs to Lead Sanofi Greater China

CompanyDrug

Merck KGaA’s Erbitux Approved in China for Head and Neck Cancer Treatment

Show More